Former pharmaceutical executive Martin Shkreli is seeking new representation in his fight against securities fraud charges.
Shkreli’s attorneys filed a letter requesting new counsel and delayed a status conference scheduled for Wednesday, Bloomberg reports.
From Bloomberg:
The lawyers said issues arose over the holiday weekend. On Jan. 17, Shkreli allowed a reporter for New York’s Fox 5 TV station to come to his apartment for an interview in which he complained about being called a “pharma bro” in the press. He described the criminal case against him as “fictitious.”
“We respectfully request a two-week continuance of the scheduled conference so that Mr. Shkreli can finalize his engagement of new counsel and we can properly transition the matter to the new attorneys,” lawyers Marcus Asner and Baruch Weiss said in the letter, dated Jan. 18.
Shkreli, 32, faced controversy in September for drastically increasing the price of Daraprim, a life-saving drug.
The founder of hedge funds and pharmaceutical companies was arrested last month under suspicion of securities fraud. He has pleaded not guilty and was released on bond.
Photo by NEPA Scene via Flickr CC License
